Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,816.89
(
-0.11%
)
US TECH 100
24,286.80
(
-0.64%
)
Dow Jones
47,916.57
(
-0.56%
)
Brent Oil
99.25
(
-0.61%
)
Bitcoin
70,743.04
(
-0.04%
)
News Focus
News Focus
Post# of 257392
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122862
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: drbio45 post# 3315

Wednesday, 08/25/2004 9:07:43 PM

Wednesday, August 25, 2004 9:07:43 PM

Post# of 257392
>> it says only one of the eyetech dose levels reached statistical significance but it looks like the .3 and the 1mg dose did… One of the two trials for the 1 mg dose demonstrated statistical significance (p=.0273 and p=.0035) <<

When a clinical trial tests multiple doses, the p-value threshold for statistical significance is reduced accordingly. Since EYET was testing three doses, statistical significance was defined as p<.0167 (i.e. .05/3). By this definition, the 1mg dose failed on one of the two trials.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today